NASDAQ$SEER
Seer Inc · Q1 2025 earnings
Q1 2025 earnings · · After market close · Investor relations
Briefing
Seer reported Q1 2025 revenue of $4.2 million, driven by strong product and service sales, and reiterated its full-year revenue guidance.
Seer achieved $4.2 million in revenue during Q1 2025, reflecting 37% year-over-year growth. Improved gross profit of $2.1 million and a stable cash position of $285 million highlighted the quarter, though net losses persisted at $19.9 million.
- Revenue grew 37% YoY to $4.2 million in Q1 2025
- Gross margin improved to 49% with gross profit of $2.1 million
- Operating expenses declined 14% due to lower stock-based compensation
- Cash, cash equivalents, and investments stood at $285 million at quarter-end
Headline financials
Revenue & EPS history
Seer · Revenue · Quarterly
$4.21M
Revenue by segment
Seer · $3.81M total across 3 segments · Q3 2023
- Product Revenue$1.85M-28.1%48.5%
- Related Party Revenue$1.43M+8.6%37.5%
- Service Revenue$536K-21.8%14.1%
Forward guidance
Seer reiterated its full-year 2025 revenue guidance of $17–18 million, aiming for 24% growth at the midpoint. The company remains confident in long-term market adoption of its Proteograph platform despite macroeconomic volatility.
Tailwinds
- Full-year 2025 revenue guidance reaffirmed at $17–18 million
- Signed major customer contract for 10,000-sample study
- Shipped as many instruments in Q1 2025 as all of 2024
- Strong validation through third-party publications and preprints
- Operating expenses decreased due to reduced stock-based comp
Headwinds
- Net loss of $19.9 million remains significant
- Continued macroeconomic headwinds for life sciences industry
- Gross margin below 50%, limiting profitability
- Reduction in related party revenue YoY
- Decline in interest income compared to prior year
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2025
-1.1%
Avg return
Earnings day
-3.4%
Avg return
5 days after
-1.3%
Avg return
30 days after
38%
9 / 24 earnings
Positive
+39.4%
Q4 2022
Best reaction
-33.3%
Q2 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.7% | -7.7% | — | |
| Q4 2025 | -17.4% | -11.1% | -20.2% | |
| Q3 2025 | -1.4% | -4.6% | -13.4% | |
| Q1 2025 | +10.0% | +7.8% | +7.8% | |
| Q4 2024 | -4.5% | -7.3% | -20.9% | |
| Q3 2024 | +9.4% | +10.3% | +22.2% | |
| Q2 2024 | +0.0% | -1.2% | -4.7% | |
| Q1 2024 | -6.8% | -10.0% | -21.7% | |
| Q4 2023 | +1.1% | +6.1% | +5.6% | |
| Q3 2023 | -7.4% | -11.4% | -5.1% | |
| Q2 2023 | -33.3% | -40.6% | -43.6% | |
| Q1 2023 | -2.2% | -11.2% | +33.7% | |
| Q4 2022 | +39.4% | +20.8% | -1.3% | |
| Q3 2022 | -3.4% | +22.0% | -7.4% | |
| Q2 2022 | +19.5% | +6.9% | -12.4% | |
| Q1 2022 | +5.5% | -5.7% | +5.7% | |
| Q4 2021 | -6.6% | -15.3% | +1.8% | |
| Q3 2020 | -11.4% | -13.5% | -31.0% | |
| Q3 2021 | -11.4% | -13.5% | -31.0% | |
| Q2 2021 | +8.1% | -0.8% | +44.5% | |
| Q2 2020 | +8.1% | -0.8% | +44.5% | |
| Q1 2020 | -11.4% | -8.8% | +4.1% | |
| Q1 2021 | -16.1% | -22.2% | -17.9% | |
| Q4 2020 | +7.6% | +29.9% | +31.1% | |
| Q4 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro